hydroxychloroquine and buparlisib

hydroxychloroquine has been researched along with buparlisib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ju, W; Kim, CY; Kim, HJ; Kim, SC; Kim, YH; Lee, SY1
Chen, ZS; Claret, FX; Elkabets, M; Jiao, W; Kong, D; Peng, X; Wang, F; Wang, R; Yang, Y; Zhang, S; Zhong, Y; Zhong, Z1

Other Studies

2 other study(ies) available for hydroxychloroquine and buparlisib

ArticleYear
Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.
    Oncotarget, 2017, Jan-24, Volume: 8, Issue:4

    Topics: 14-3-3 Proteins; Active Transport, Cell Nucleus; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Biomarkers, Tumor; Breast Neoplasms; Class I Phosphatidylinositol 3-Kinases; Cytoplasm; Dose-Response Relationship, Drug; Female; Forkhead Box Protein O3; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Hydroxychloroquine; Morpholines; Mutation; Protein Kinase Inhibitors; RNA Interference; Signal Transduction; Time Factors; Transfection; Uterine Cervical Neoplasms

2017
Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy.
    Journal of experimental & clinical cancer research : CR, 2021, Nov-29, Volume: 40, Issue:1

    Topics: Aminopyridines; Animals; Autophagy; Humans; Hydroxychloroquine; Mice; Mice, Nude; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Zebrafish

2021